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Purpose: Retinitis pigmentosa (RP) is a progressive retinal degeneration in which the retina loses nearly all of its
photoreceptor cells and undergoes major structural changes. Little is known regarding the role the resident glia, the Müller
glia, play in the progression of the disease. In this article, we define gene expression changes in Müller glial cells (MGCs)
from two different mouse models of RP, the retinal degeneration 1 (rd1) and rhodopsin knockout (Rhod-ko) models. The
RNA repertoire of single MGCs was comprehensively profiled, and a comparison was made between MGCs from wild-
type (WT) and mutant retinas. Two time points were chosen for analysis, one at the peak of rod photoreceptor death and
one during the period of cone photoreceptor death.
Methods: Retinas were dissociated, and single MGCs were chosen under a dissecting microscope using a micropipette.
Single cell cDNAs were generated and genome-wide profiles were obtained by hybridization to Affymetrix arrays. A
comparison was made among all samples to discover the changes in gene expression during the periods of rod and cone
photoreceptor death.
Results: MGCs respond to retinal degeneration by undergoing gliosis, a process marked by the upregulation of glial
fibrillary acidic protein (Gfap). Many additional transcripts were found to change. These can be placed into functional
clusters, such as retinal remodeling, stress response, and immune-related response.
Conclusions: A high degree of heterogeneity among the individual cells was observed, possibly due to their different
spatial proximities to dying cells and/or inherent heterogeneity among MGCs.
Many degenerative diseases of the retina involve the loss
of photoreceptor cells. These diseases most often are due to
mutations  that  directly  affect  the  photoreceptor  cells
(RetNet).  Other  cell  types,  such  as  neurons  that  are
postsynaptic to photoreceptor cells, as well as glial cells, are
indirectly  affected  by  these  changes  within  photoreceptor
cells. Müller glial cells (MGCs) are the predominant type of
glial cell in the vertebrate retina. They are likely sensitive to
changes in the status of photoreceptor cells, as MGC processes
ensheathe the photoreceptors, and MGCs offer various types
of support to the photoreceptor cells (reviewed in [1]). Müller
glial cell bodies localize to the middle of the inner nuclear
layer.  In  addition  to  processes  that  ensheathe  the
photoreceptors, MGC radial cell processes span the entire
retina. In contrast to glial cells in other regions of the central
nervous system, where the cells greatly outnumber neurons,
MGCs account for only 2% to 5% of the total retinal cell
population  [2,3].  In  the  healthy  retina,  they  contribute  to
various essential functions, including structural support to
neurons,  neurotransmitter  recycling,  regulation  of  ion
homeostasis,  glia-neuron  communication,  glutamate
metabolism, maintenance of the blood–retinal barrier, and
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energy provision [1,4,5]. They also have been reported to
function as light pipes that transmit light across the retina to
the photoreceptors [6]. MGCs are dynamic cells that express
many  receptors  that  enable  the  cells  to  respond  to  their
environment [4]. They can react to various molecules such as
neurotransmitters, growth factors, and cytokines. MGCs can
also modify neuronal activity by secreting various growth and
neurotrophic factors [7-12].
MGCs respond to insults to the retina through a process
referred to as gliosis [1,13]. The function of gliosis is poorly
understood.  Even  fundamental  aspects,  such  as  whether
gliosis is protective or destructive, are not understood [1,14].
No  studies  have  been  performed  to  systematically
characterize the gene expression response of MGCs during
the progress of retinitis pigmentosa (RP), a common inherited
disorder of the retina (Retnet). The most well known aspect
of the glial response is that MGCs upregulate the intermediate
filament protein, the glial fibrillary acidic protein (GFAP), a
protein considered a marker for reactive gliosis not just in the
retina but across the entire central nervous system (CNS)
[13,15]. GFAP expression is increased in response to a wide
range of insults. In other areas of the CNS, gliosis has been
suggested  to  have  numerous  beneficial  functions,  such  as
providing a physical barrier that protects tissue from further
damage  [16-20].  However,  studies  also  have  suggested
detrimental effects, such as inhibition of axon regeneration
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1197[20-22]. In the retina, the functional consequences of gliosis
are unclear.
Retinitis  pigmentosa  (RP)  is  an  inherited  disorder
characterized  by  an  initial  phase  of  rod  photoreceptor
dysfunction and death, followed by cone death. RP has an
incidence of about 1 in 3,500–4,000 people [23]. Mutations
have been identified in more than 40 genes, with many of these
genes expressed only in rods. In fact, the locus with the highest
number of disease alleles for the autosomal dominant form of
RP is the rhodopsin locus. The current study used two animal
models of RP, with mutations in two different rod-specific
genes.  One  mutation  is  in  the  rhodopsin  locus,  where  no
protein is made (Rhod-ko) [24], and the other is in the Pdeb
(phosphodiesterase beta) locus where a non-functional protein
is made (rd1) [25]. The disease progression in the retina in the
two models differs in the kinetics of degeneration. However,
both have the same outcome, loss of photoreceptors resulting
in a total collapse of the outer nuclear layer [24-26]. In a
patient,  these  two  phases  of  photoreceptor  cell  death
correspond to an initial loss of night vision, followed by tunnel
vision. Eventually, an individual with RP loses all vision.
To create a data set that can be further explored regarding
the function of MGCs during gliosis, we sought to create a
comprehensive  catalog  of  changes  in  gene  expression  in
MGCs during RP. As MGCs are only a small percentage of
all cells in the retina [3], we chose to profile several single
MGCs  from  wild-type  (WT)  and  diseased  retinas.  The
transcription profiles of single MGCs at two different stages
of disease and in the two models of RP mentioned above were
established using Affymetrix microarrays. The data from each
cell were compared to profiles from WT controls, as well as
each other’s profiles. We used the five previously published
MGCs  characterized  by  our  laboratory  as  the  adult  WT
controls [27]. We also profiled three additional WT glial cells
picked from a WT strain congenic with the strain carrying the
rd1 mutation. The results provide a survey of molecules with
increased  or  decreased  expression  in  MGCs  during
photoreceptor cell death. A substantial number of genes were
found to be coregulated with the gliosis marker Gfap. We
discuss how these changes might alter MGC activity and how
these changes might affect the surrounding neurons. More
detailed  knowledge  of  the  role  of  MGC  gliosis  during
photoreceptor  cell  loss  could  potentially  lead  to  novel
concepts and ideas for therapeutic strategies for RP.
METHODS
Animals: WT mice (C57/BL6) and rd1 (FVB) mice were
purchased  from  Charles  River  Laboratories  (Wilmington,
MA). The rd1 mice carry a mutation in the β-subunit of cGMP
phosphodiesterase  (PDE6B).  Congenic  FVB  mice  were
purchased from Jackson Laboratories (stock number 4828l,
FVB.129P2-Pde6b+Tyrc-ch/AntJ;  Bar  Harbor,  ME).  The
Rhodopsin knockout (Rhod-ko) mice are deleted in the rod-
specific rhodopsin gene and were a gift from J. Lem (Tufts
University, Boston, MA) [24].
Isolation of single Müller glial cells and cDNA amplification:
Isolation  of  single  MGCs  and  cDNA  amplification  were
performed as described in [27-31]. Retinas were dissected
from  several  different  litters  of  Rhod-ko  and  rd1  (FVB)
animals at 8 and 25 weeks, and at 13 days postnatal (P13) and
5 weeks of age, respectively, as well as at P13 from the control
congenic FVB mice. The retinas were dissociated with papain
(Worthington  Biochemical,  Freehold,  NJ)  with  gentle
trituration. Dissociated cells were viewed under a dissecting
microscope, and MGCs were selected as single cells based
upon their distinct morphology. cDNAs were generated with
reverse  transcription  using  Superscript  II  (Invitrogen,  La
Jolla, CA) and a modified Oligo dT primer: TAT AGA ATT
CGC GGC CGC TCG CGA TTT TTT TTT TTT TTT TTT
TTT  TTT  (Oligos  Etc.,  Wilsonville,  OR),  followed  by
poly(A)  tailing  using  TdT  (Roche,  Nutley,  NJ),  and
polymerase chain reaction (PCR) amplification using LA Taq
polymerase (Takara Mirus Bio, Shiga, Japan) [31].
Affymetrix  array  hybridization:  Detailed  procedures  have
been previously described in Trimarchi et al. [31] and Roesch
et al. [27]. Briefly, samples were labeled with 25 uM biotin
N6  ddATP  and  hybridized  to  mouse  genome  430  2.0
Genechip oligonucleotide arrays (Affymetrix, Santa Clara,
CA). The slides were scanned using a GeneChip Affymetrix
Scanner 7G. Signals from microarrays were further processed
by using Affymetrix MicroArray Suite Software (MAS 5.0).
The resulting data were exported as tab delimited text files to
Microsoft  Excel  (Microsoft  Corporation,  Redmond,  WA;
Microsoft Excel 2008 for mac, version 12.2.5). Appendix 1
lists the signal levels for all cells profiled in this study and the
previously published WT MGCs [27] used for comparison.
The raw and processed data files can be accessed through
NCBI Gene Expression Omnibus (GEO) Series accession
number GSE35386.
Data  analysis:  A  detailed  description  of  Affymetrix  data
analysis has been previously published in Trimarchi et al.
[31] and Roesch et al. [27]. Multiple probe sets corresponding
to a single gene were combined by selecting whatever probe
set gave the highest value in a particular cell, and median
expression levels were calculated. From the distribution of
median expression levels (x-Axis is logarithmic), an initial
peak of low expressed genes (probably off) can be observed,
followed by a tail on the right side (probably on; see “median
expression distribution” in Appendix 2). Already the lowest
median expression threshold of 500 separated this tail from
the initial peak, and higher stringencies of 1,000 and 2,000
worked  even  better.  From  the  initial  approximate  20,000
genes, this filtering on the median expression retained about
6%–12% of the genes: 3,519 genes, 2,368 genes, and 1,508
genes for thresholds of 500, 1,000, and 2,000, respectively.
To  analyze  the  coregulated  genes,  a  median  expression
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higher level than the threshold) for an upregulated gene to be
included in the analysis was set to 2,000, and any other gene
that  did  not  fulfill  this  criteria  was  filtered  out.  For
downregulated genes, a median expression threshold of 2,000
had to be achieved by at least three out of five cells in the WT
samples. The resulting scaled values were equally distributed
into  five  bins.  Probe  set  pairs  were  then  analyzed  for
association  using  a  contingency  table,  and  a  p  value  for
significance was calculated using Fisher’s exact test. The data
are  represented  in  table  format  or  visualized  in  Java
TreeView (version 1.1.5r2) [32]. Tables contain the resulting
p values of coregulation of any gene (row) with the gene of
interest(s).
RESULTS AND DISCUSSION
Gene  expression  changes  during  gliosis  defined  with
microarray analysis: MGCs were isolated from dissociated
retinas at several time points. As the morphology of single
MGCs following dissociation is characteristic, this criterion
was  used  for  their  selection  [27].  The  signals  from  the
microarrays confirmed that these cells were indeed MGCs
(e.g., see the signal for vimentin [Vim]). Single cells were
collected at the peak of the rod and cone cell death phases.
Death  kinetics  in  both  models  in  our  colony  have  been
previously established and described in Punzo et al. [26]. In
the rd1 model, the peaks of the two cell death waves are at
P12 and week 5. In the Rhod-ko model, the corresponding
time points are 8 weeks and 25 weeks. To examine whether a
known marker of gliosis, Gfap, was upregulated in the MGCs
from  the  mutants,  the  RNA  levels  for  this  gene  were
examined. Robust expression of Gfap was found in most cells
(four of five) from the Rhod-ko and rd1 model at the early
time point. At the late time point in rd1, five of five cells
expressed Gfap, and only one of five of Rhod-ko cells also
had significant levels at the later time point. No RNA was
Figure  1.  Single  cell  transcriptional
profiles of genes highly associated with
Gfap. Single MGCs were picked from
dissociated retinas from two strains of
degenerating  retinas  and  from  WT
retinas. Single cell RNAs were reverse
transcribed,  amplified  with  PCR,  and
applied  to  Affymetrix  microarrays.
Columns  represent  the  signal  from
single  cell  samples,  rows  represent
genes.  A  heatmap  was  generated  in
TreeView such that bright red represents
>10,000,  and  black  <1,000,  varying
shades of red the values in between. A
Fisher’s exact test was run to find genes
that  were  coregulated  with  Gfap
(Affymetrix  identifier  X1426508_at).
All the top hits for genes coregulated
with  Gfap  and  their  corresponding  p
values  are  shown.  MGC  samples:
WT=wild-type,  Rhod-ko=Rhodopsin
knockout  model,
rd1=phosphodiesterase  beta  1  rd1
mutant on the FVB strain background,
and cong FVB is a WT control for rd1
on a congenic FVB background. Time
points chosen are >21 days for WT, and
8 weeks and 25 weeks for the peaks of
the two cell death waves in the Rhod-ko
model. The corresponding time points in
the  rd1  are  postnatal  day  P13  and  5
weeks. MGCs from congenic FVB at
P13 were profiled as WT samples that
are better age matched to the early cell
death wave in the rd1 model.
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1199detected in the WT cells at the adult stage (zero of five) or at
P13 (zero of three) in the congenic rd1 animals.
To identify other genes induced during gliosis, we ran an
analysis  to  look  for  genes  coregulated  with  Gfap.  The
microarray  signals  for  each  gene  across  all  cells  were
compared to the signals for Gfap in each cell. The probability
that the observed pattern of expression for Gfap and each gene
was by chance was computed using Fisher’s exact test. In
Appendix  3  “p-vals  distribution,”  the  number  of  genes
coregulated  with  Gfap  are  plotted  against  their  p  values
(Appendix 4, Appendix 5, Appendix 6). The expression levels
for a selected subset of genes with significant p values are
represented  in  detail  as  a  heatmap  in  Figure  1.  Clearly
noticeable is a cluster of upregulated genes at the peak of rod
cell loss in the Rhod-ko. Similar clusters, though at lower
expression levels and more variegated, can be observed across
the MGCs taken from the degenerating rd1 retinas at either
time point. In the sections below, we discuss and speculate
about the potential roles of the genes that exhibit changes in
expression levels, as well as the difficulties encountered in our
approach.
Challenges in profiling single Müller glial cells: There are
two advantages to using single MGCs for this analysis. As
mentioned above, the percentage of MGCs in the WT retina
is only 2%–5% [3]. Total tissue RNA preparations thus will
not reveal genes that are at modest or low levels of expression
within MGCs. Second, our previous single cell profiling of
many types of retinal cells was undertaken with single retinal
cells  as  we  wished  to  examine  cell  types  for  their
heterogeneity. As WT MGCs were included within this set, it
was then a control set for comparing MGCs from diseased
retinas. Examining the heterogeneity of response of MGCs to
disease  was  also  of  interest.  Previous  studies,  which
characterized the entry of MGCs into the cell cycle following
acute insults, showed that only a subset of MGCs responded
by entering the cell cycle [33-39]. Single cell profiles might
thus  contribute  to  an  understanding  of  this  type  of
heterogeneity in the cellular response.
Only a handful of highly significant results were obtained
(in the order of what is expected by chance given the p value
cutoff).  That  does  not  necessarily  mean  that  the  results
obtained  are  purely  random—but  that  the  type  of  data
analyzed is rather noisy, thus limiting the statistical power.
The  obtained  ranking  of  genes  will  still  tend  to  put  the
biologically important ones toward the top of the list. In this
case,  there  could  be  many  false  positives  among  the
potentially true positives. However, there is also a difficulty
inherent  in  using  single  cell  profiling  to  unmask
heterogeneity. If heterogeneity is significant, it presents a
burden  in  statistical  analysis.  This  problem  is  difficult  to
address because in the case of single cell expression data,
replicates are not available. The low number of significant
results in this data set might also depend on the additional
filters applied (e.g., median expression level). This makes the
analysis more stringent and goes beyond what the p value
expresses. Nevertheless, it is a fair assumption that the data
are relatively noisy and the statistical power is limited.
MGCs have been suggested to form functional columns
with neurons as well as with each other [40-42]. In rodents,
up to approximately 30 rods can be associated with one MGC
[43]. Interestingly, cones do not belong to these columnar
units, and are considered “extra-columnar” [43]. Within a
column, MGCs are assumed to communicate with each other
in coordinated ways via gap junctions [44]. MGCs can be
Figure  2.  Key  features  of  gliosis.  A
subset of genes with significant p values
(<0.01) compared with Gfap expression
were distributed into functional groups.
Signals from the Affymetrix chip have
been  scaled  such  that  bright  red
represents >10,000, and black <1,000,
varying  shades  of  red  the  values  in
between.
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1200recruited to or can leave the column, but neighboring columns
do not necessarily have to provide the same function [45]. In
keeping with this idea, we found significant heterogeneity
among WT MGCs in our previous study [27]. Heterogeneity
in disease response might then be expected due to this inherent
heterogeneity  among  the  WT  cells.  Additional  variability
likely would stem from the different ages and time points at
which cells were collected in different mutant animals as well
as from differences in the location of individual cells. Cell
death in RP spreads from the center to the periphery of the
retina, and therefore, cells originating from the center versus
the  periphery  might  differ.  In  the  teleost  retina,  spatial
diversity and heterogeneity have been previously suggested
based on variable levels of proliferation among MGCs in
correlation with the most severely damaged photoreceptors
[46]. However, even in one location, not all MGCs enter into
the cell cycle following an insult, suggesting heterogeneity in
response even in one location [39,47,48].
Validation  of  the  microarray  results  using  in  situ
hybridization (ISH) for genes that change in MGCs during
disease was undertaken. However, the results were difficult
to interpret. Glial transcripts are dispersed throughout the cell
body, resulting in ISH signals that are diffuse. Additionally,
slow degeneration due to photoreceptor cell loss, particularly
as occurs in the Rhod-ko retina, likely does not give striking
changes in MGCs. Finally, staining observed at the inner and
outer  limiting  membranes,  structures  defined  by  MGC
processes, was difficult to assess, as non-specific staining was
sometimes observed in these locations. All of these features
made  quantitative  comparison  among  MGCs  using  ISH
difficult. However, in our previous studies of many types of
single retinal cells, we performed ISH using several hundred
probes to examine gene expression patterns suggested by the
microarrays [31,49]. In each case, the microarray data were
shown to accurately represent the expression pattern. These
data suggest that the changes observed among the microarrays
in the current study likely reflect changes in gene expression
during gliosis among some of the MGCs.
Gene expression changes during gliosis: Possible functional
consequences: The types of processes that one might predict
would occur during photoreceptor death include removal of
cell debris, restoration of homeostasis, arrest of secondary
degeneration,  sealing  of  the  lesion  site,  and  tissue
reorganization. MGC gliosis likely contributes to some of
these aspects. The gene expression changes seen here do in
fact  support  these  roles  for  MGCs  during  photoreceptor
degeneration.  The  results  discussed  below  focus  on  these
features.
Remodeling: As the retina loses all of its photoreceptors, the
outer nuclear layer collapses. However, the inner neural retina
remains relatively intact for an extended period, although
there are changes in the neuronal processes [50]. Eventually,
many cells in the inner layer also die. There is evidence that
MGC gliosis may play a role in protecting the retina from the
spread of cell death by establishing new boundaries [51].
Indeed, one of the genes with the most prominent association
Figure 3. Gliosis-cell cycle reentry and
proliferation.  A  Java  TreeView-
generated  heatmap  illustrating  the
expression of genes involved in control
of  the  cell  cycle  and  proliferation.
Signals from the Affymetrix chip have
been  scaled  such  that  bright  red
represents >10,000, and black <1,000,
varying  shades  of  red  the  values  in
between.
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1201with Gfap is plectin (Figure 2), a linker molecule among the
three  main  components  of  the  cytoskeleton  and  between
plasma  membrane  junctions.  Other  intermediate  and
microfilament related genes, such as vimentin and stathmin 1
(a regulatory protein of microtubule dynamics), are highly
expressed in MGCs from WT and mutant retinas (Figure 2).
High expression levels of intermediate filament proteins and
associated proteins might suggest that a stabilization of MGC
processes takes place. Interestingly, the intermediate filament
nestin, expressed by neural progenitor cells [52], can also be
upregulated in a subset of gliotic MGCs (see the full data set
in  Appendix  1).  Integrins,  receptors  that  mediate  cell
attachment as well as mobility, are also strongly associated
with Gfap expression (Appendix 2).
Stabilization of MGC processes could additionally be
important for the formation of new boundaries between the
apical  processes  of  the  MGCs  and  the  retinal  pigment
epithelium (RPE). These boundaries might protect the retina
from further damage, such as intrusive pathogenic factors
produced by a possibly ruptured RPE. The newly formed
boundaries can be considered light scarring between the retina
and the RPE [53]. However, no glial scar in the traditional
understanding  of  a  central  nervous  system  (CNS)  scar  is
formed. No molecules known to be expressed in reactive
astrocytes and microglia have been found in the MGC profiles
[54-58].  In  this  data  set,  expression  of  the  inhibitory
extracellular  matrix  molecule,  CD44  antigen  (Cd44),  was
increased in MGCs during cone degeneration in both models
(Appendix 1). Chondroitin sulfate proteoglycan, Cspg5, was
upregulated in a subset of MGCs at early time points and in
most cells at later time points. However, no other Cspgs are
expressed in MGCs. We also found increased hyaluronan
expression in the degenerating retina stained with Alcian blue
(Alcian Blue 8GX; Sigma–Aldrich, St. Louis MO; Roesch
and Cepko, data not shown). All of these data might point to
a targeted response within MGCs directed at the extracellular
matrix and the structure of MGCs themselves. Indeed, altered
expression  of  adherens  junction  proteins  in  the  Rhod-ko
mouse has been previously reported [59]. Additionally, the
outer limiting membrane (OLM) has been shown to be a
barrier  for  PR  engraftment  in  the  rat  [60,61].  The  OLM
contains intracellular junctions between PR and MGCs that
Figure  4.  Gliosis–progenitor  cell
potential.  A  heatmap  created  in  Java
TreeView displaying the expression of
selected progenitor cell genes across the
MGC  samples.  Signals  from  the
Affymetrix chip have been scaled such
that bright red represents >10,000, and
black <1,000, varying shades of red the
values in between.
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1202are  defined  by  expression  of  Cd44  [62]  and  intercellular
adhesion molecule 1 (Icam-1) [63]. In addition, disruption of
the OLM by deletion of the Crumbs homolog 1 (Crb1) and
zona occludins (Zo-1) helps with integrating transplanted PR
[60,61].
Detoxification:  During  photoreceptor  cell  loss,  MGCs  are
exposed to a changing environment. Changes likely include
an  imbalance  in  ions,  oxygen  concentration,  and  reactive
oxygen  species  and  inflammation,  all  of  which  could
potentially be toxic. Genes found to be strongly associated
with Gfap might thus be “detoxifying” genes. We observed
upregulation  of  the  antioxidant  gene,  glutathione-s-
transferase (Gst1; Figure 2), that can protect neurons through
a reduction in reactive oxygen. Interestingly, MGCs from
older mice have been shown to contain a reduced amount of
glutathione  compared  to  younger  ones  [64],  which  could
potentially  be  a  modifier  for  disease  progression  in  the
different models. Transcripts for peroxiredoxins (Prdx2) were
also found to be upregulated, which could lead to a reduction
in  H2O2  and  other  peroxides  in  the  retinal  tissue.  Other
molecules  involved  in  stress  protection  with  increased
expression levels and strong association with Gfap were the
antioxidant metallothionein 1 (Mt1), which binds toxic metals
and acts as free radical scavenger, superoxide dismutase 1
(Sod1),  and  genes  involved  in  iron  homeostasis,  e.g.,
ceruloplasmin,  a  copper  binding  ferroxidase.  Nitric  oxide
synthase was upregulated as well, especially at the early time
points in Rhod-ko and rd1 MGCs, even though the synthase
did not associate well with Gfap expression (Appendix 1).
Nitric  oxide  function  at  low  concentration  should  be
beneficial  and  protect  neurons  from  glutamate  toxicity.
Increased  nitric  oxide  synthase  expression  has  been
previously  shown  in  response  to  ischemia  and  diabetic
retinopathy [65,66]. Glutamine synthetase (Glul), the only
retinal enzyme that can perform ammonia detoxification, was
highly expressed in WT MGCs as well as glial cells from the
degenerating retinas [67], and therefore did not associate well
with Gfap. Removal of large molecules from extracellular
space  by  multidrug  resistant  transporters  in  the  glial
membrane has been suggested previously [68]; however, none
of  these  genes  were  present  in  the  data  set.  The
aforementioned changes in glutathione metabolism, peroxide
detoxification, and iron homeostasis could all potentially lead
to neuronal protection.
Figure  5.  Gliosis–regenerative
potential.  A  heatmap  created  in  Java
TreeView  shows  the  expression  of  a
selection  of  genes  common  to
regeneration  across  MGCs.  Signals
from  the  Affymetrix  chip  have  been
scaled such that bright red represents
>10,000,  and  black  <1,000,  varying
shades of red the values in between.
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1203Growth factors: Neurotrophic factors, growth factors, and
cytokines  (see  below)  have  previously  been  suggested  to
positively  affect  the  survival  (and  synaptic  function)  of
neurons.  MGCs  produce  the  neurotrophins,  nerve  growth
factor  (NGF),  brain-derived  neurotrophic  factor  (BDNF),
ciliary neurotrophic factor (CNTF), basic fibroblast growth
factor (bFGF), insulin-like growth factor 1 (IGF-1), glial cell-
derived  neurotrophic  factor  (GDNF),  leukemia  inhibitory
factor  (LIF),  and  pigment  epithelium-derived  factor  318
(PEDF318)  [69].  Many  of  these  factors  lead  to  increased
glutamate buffering [70,71] and might enhance photoreceptor
survival. In the data set presented here, nerve growth factor-
β (Ngfbeta) expression was high in a subset of WT cells but
low in the remaining cells. Cntf was highly expressed in early
stages of rd1 and Rhod-ko. However, Cntf expression was not
well correlated with Gfap. Other neurotrophic factors, such as
Bdnf,bFgf,Igf1,Gdnf,Lif,  and  Pedf,  were  not  expressed.
Further, dickkopf homolog 3 (Dkk3) was highly expressed in
WT and all Rhod-ko samples (Appendix 1). Interestingly,
Dkk3 expression was low in congenic FVB (WT) at P13, but
high in FVB rd1 MGCs at P13. The suggested function of
DKK3 is to reduce caspase activity through wingless (Wnt)
signaling and to protect against cell death [72,73]. Indeed, it
has  been  previously  shown  that  the  Wnt  pathway  can  be
activated in MGCs after photoreceptor death [73].
Homeostasis  and  energy  metabolism:  MGCs  have  been
shown to support neurons in a WT situation through their roles
in  maintaining  extracellular  homeostasis,  including
transporting  and/or  buffering  water,  potassium  ion  (K+),
glutamate,  and  other  ions  [74].  MGCs  are  proposed  to
transport waste products, and exchange molecules with retinal
blood vessels, vitreous body, subretinal space, and the RPE
[4]. Francke et al. [75] showed that depolarized membrane
potentials  and  reduced  K+  inward  conductance  indeed  do
occur in reactive rabbit MGCs, which in turn also suggests an
impairment  in  the  clearance  of  excessive  K+  ions  and
neurotransmitter  recycling.  Interestingly,  depolarization  of
the resting potential seems to be a requirement for astrocyte
proliferation [76]. One gene associated with Gfap that falls in
this category is potassium channel tetramerisation domain
containing 2 (Kctd2), found to be mainly upregulated in the
Rhod-ko MGCs (Figure 2). However, we did not observe any
other changes in the expression levels of genes concerned with
homeostatic activities.
Another aspect of cellular stress response on the part of
glia is the provision of energy to neurons. In the degenerating
retina, Punzo et al. [26] have shown that cone photoreceptors
appear  to  be  starving.  In  the  healthy  retina,  it  has  been
proposed  that  MGCs  nourish  neurons  with  lactate  and
pyruvate that can be used by neurons to make ATP [77], and
similar models have been made for other glia elsewhere in the
CNS [78]. MGCs can store energy in the form of glycogen
and can use glycogenolysis to break it down, depending upon
neuronal  activity  [74].  Indeed,  the  glia-specific  protein,
glycogen phosphorylase, is upregulated in a subset of MGCs
from degenerating retinas (Appendix 1). Interestingly, MGCs
are not dependent on the presence of oxygen and can undergo
anaerobic glycolysis [77]. However, when glucose is absent,
MGCs can use lactate, pyruvate, glutamate, or glutamine to
make  energy  [79].  Many  transcripts  involved  in  energy
metabolism, such as glucose phosphate isomerase 1, lactate
dehydrogenase  A,  and  pyruvate  kinase,  were  slightly
upregulated or were steady across most Rhod-ko- and rd1-
derived MGCs (Appendix 1).
Immune response and inflammation: Efficient elimination of
apoptotic cells during degeneration is assumed to be crucial
for  regulating  the  immune  response  and  preventing  a
potentially devastating inflammatory reaction in all tissues.
The retina is traditionally looked at as an immune-privileged
site  [80].  However,  the  retina  carries  out  an  innate  and
adaptive  immune  response  [81-83].  The  innate  immune
response  relies  largely  on  phagocytic  cells–expressing
receptors that recognize molecular patterns on apoptotic cells
to  distinguish  them  from  living  cells.  After  binding  to
apoptotic  cells,  anti-inflammatory  signals  and  other
immunomodulatory cytokines are released by the cells of the
immune system, but perhaps, as discussed below, also by
MGCs. MGCs are thought to be important mediators of short-
range  interactions  among  retinal  cells  [4],  and  therefore,
MGCs  might  act  as  modulators  of  the  immune  and/or
inflammatory response and might spatially and temporally
restrict it. MGCs could be the cell type that recognizes the
death of photoreceptors and might communicate this to other
cell types in the retina. MGCs might also send the signals that
recruit  microglia.  Alternatively,  or  additionally,  microglia
that migrate into the retina could release molecules that trigger
gliosis in MGC.
Indeed, upregulation of Gfap in MGCs is associated with
recruitment  of  microglia  into  the  retinal  tissue.  Usually,
astrocytes and microglia in the healthy retina are confined to
the innermost retinal layers (nerve fiber layer, ganglion cell
layer,  inner  plexiform  layer).  Monocyte  chemoattractant
protein 1 (MCP-1, CCL-2) expression was shown in MGCs
after  retinal  detachment  [84,85].  MGCs  also  secrete  the
proinflammatory cytokine tumor necrosis factor α (TNF-α)
[86-89]. MCP-1 and TNF promote infiltration by immune
cells. Interestingly, there was upregulation of TNF-α induced
protein 1 (Tnfaip1) in MGCs from the RP retinas, suggesting
that  MGCs  are  responsive  to  it  as  well  (Figure  2).  The
antioxidant, heme oxygenase, can decrease recruitment of
immune  cells  into  retinal  tissue,  and  its  transcript  was
observed to be upregulated in MGCs during degeneration
[90] (Appendix 1). It is possibly also regulated by Icam-1,
which shows increased expression levels in a subset of MGCs
from  RP  retinas  [91].  Other  chemotactic  factors  for
macrophages and monocytes upregulated in the single MGCs
are  monocyte  to  macrophage  dissociation  associated  2
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1205(Mdm2) and macrophage migration inhibitory factor (Mif1).
Also upregulated was the transcript for CCAAT/enhancer
binding  protein  delta  (Cebpd),  a  protein  that  regulates
macrophage activation genes. See the full data set in Appendix
1 for detailed expression on all of these.
In the data set presented here, there are indications of an
immune-related response. Some MGCs showed upregulation
of  cytokine  and  cytokine  receptor  genes,  as  well  as
complement  components.  Some  components  of  the
chemokine system (Xcr1 and Cxcl16) also can be detected in
WT MGCs [27]. Cxcl16 showed significant association with
Gfap (Figure 2). Several other small inducible cytokines and
their receptors (Ccrl1, chemokine C-C motif receptor like 1
and Ik, IK cytokine) were upregulated, too, however with less
significance than Gfap. Also strongly associated with Gfap
was complement component 4B. MGCs express the receptor
for complement C3a, and complement regulatory proteins
CD55 and CD59 [92]. However, they do not seem to be
upregulated in our data set. Previous data also showed that
astrocytes  provide  information  (intercellular  exchange  of
signaling  molecules)  to  MGCs  via  gap  junctions  [93,94].
However, tracer molecules are not passed from MGCs to
astrocytes  [95,96].  Certain  steps  (e.g.,  initiation)  might
depend upon MGCs interacting with immune cells such as
microglia [9] and might modify the amount of neurotrophic
factors  produced  by  MGCs,  which  in  turn  can  modify
neuronal survival (see the stress response section below).
MGCs  might  even  be  more  directly  involved  in  the
prompt  clearing  of  photoreceptor  debris.  MGCs  could
phagocytose PR cell debris. Their phagocytic ability has been
previously shown in vitro (latex beads) and in vivo (melanin)
after  retinal  detachment  [97-99].  During  Drosophila
development, glial cells engulf degenerating axons through
recognition  mediated  by  Drpr/Ced-1  and  Ced-6/CED-6
[100]. Researchers have proposed that apoptotic cells and
degenerating  axons  of  mature  neurons  are  removed  by  a
similar  mechanism  [100,101].  Interestingly,  MGCs  from
degenerating  retinas  in  both  models  expressed  Lgals3
(galectin-3, Appendix 1), a gene known to be expressed in
phagocytic cells and recently shown to be expressed during
glaucoma  by  astrocytes  in  the  optic  nerve  head  [102].
However, none of the prominent genes in this pathway were
found closely coexpressed with Gfap.
Cell  cycle  reentry  and  proliferation:  Cells  undergoing
reactive  gliosis  raise  the  concern  of  tumor  formation.
However, no glial tumors have been observed in the retina of
humans or animals. This suggests a tightly regulated process
of proliferation that safeguards the retina. In chicks, cells with
increased  Gfap  expression  in  response  to  damage  or
exogenous growth factors did not reenter the cell cycle [48].
In the data set presented here, a subset of MGCs, one Rhod-
ko cell picked during the rod death phase, four cells picked
during the cone death phase, and one rd1 cell during the rod
death phase, showed low to no Gfap expression (Figure 3).
Higher expression levels for cell cycle genes were observed
in two of the Rhod-ko Gfap negative cells (A1 and A2) and
in one P13 rd1 Gfap negative cell (A1). For the latter, this
might just be a general feature of a cell in a still immature
retinal environment. Across the rest of the cells, cell cycle
gene expression remained mostly low and mosaic (Figure 3).
Transcripts  for  inhibitors  of  cell  cycle  progression,
differentiation,  and  microtubule  assembly  (S100  calcium
binding  protein  A1,  A16  and  their  interacting  protein
cathepsin B) were upregulated. Expression levels of genes
associated with proliferation were low, e.g., cyclin D1 and
proliferating cell nuclear antigen (Pcna) (Figure 3). In the
CNS,  glial  cells  express  antiproliferative  molecules,  e.g.,
BMP and CNTF, even in a WT situation [103,104]. In the
MGC data presented here, Bmp1 was upregulated in the Rhod-
ko, and Bmpr2 was highly expressed across mutants. Cntf was
upregulated at early time points in Rhod-ko and rd1, and in
some  cells  in  rd1  at  later  time  points.  The  transcript  for
Cntfr was upregulated in most of the mutant cells, and was
low  in  WT  MGCs.  Other  antiproliferative  genes  such  as
Spbc25, Pea15, and Btg2 were found to be highly expressed
in the (majority of) WT cells and stayed highly expressed in
Figure  7.  Gliosis–gene  ontology
grouping  of  genes  associated  with
Emg1. A subset of these differentially
expressed genes was grouped according
to their function in a biologic processes.
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however, Spbc25 was not expressed in any of the RD1 MGCs
(Figure 3). The complete absence of this gene in rd1 might be
a reflection of genetic differences in the strain background for
rd1.
These data, as well as previously published results [48,
105], suggest that an induction of proliferation is not the case
during photoreceptor cell loss in RP. A more severe or acute
insult might be needed to trigger this activity [106]. Massive
proliferation has indeed been shown to lead to proliferative
gliosis, depolarization, and uncontrolled proliferation, and to
result in glial scar formation and further death of retinal tissue
after  vitreal  injection  of  hemoglobin,  during  proliferative
vitreoretinopathy,  proliferative  diabetic  retinopathy,  and
retinal detachment [107-109]. Additionally, proliferation and
dedifferentiation of MGCs can also be triggered in a WT
situation  after  stimulation  with  Wnt3a  and  drugs  such  as
retinoic acid and valproic acid [47].
Progenitor  cells  and  neural  repair:  MGCs  have  been
suggested to have neurogenic competence and to be a potential
source of neural regeneration. In zebrafish, MGCs indeed are
able to regenerate all retinal cells and architecture following
several types of insult [34,36,38,110]. Mature MGCs have
previously been shown to have a similar expression profile to
late retinal progenitor cells [27,111]. A late progenitor cell
likely  “morphs”  into  an  MGC  without  undergoing  an
irreversible  cell  fate  change,  whereby  the  progenitor  cell
activates the genes necessary for MGC function but does not
lose its progenitor traits [112]. Indeed, many progenitor cell
genes  are  expressed  heterogeneously  across  WT  MGCs.
Classic progenitor and late progenitor genes are more highly
expressed and expressed in more cells, at the later disease
stage of cone death (Figure 4). Interestingly, most of the
transcripts for classic progenitor genes are expressed at low
levels  in  WT  MGCs  (congenic  FVB)  at  P13,  with  the
exception of Glul and transgelin2 (Tagln2), which are highly
expressed in all three cells picked. This result might reflect
that the possibility that MGCs are maturing at P13, where they
require a very specific set of genes to fully carry out their
maturation.
Dedifferentiation  of  MGCs  to  progenitor  cells  after
photoreceptor cell loss might potentially involve functional
uncoupling  from  neurons  and  a  disruption  of  neuron-glia
interaction and homeostasis. Essential MGC functions, such
as neurotransmitter recycling (Glul), carbon dioxide (carbonic
anhydrase) and potassium siphoning, visual pigment cycling
(Cralbp), glycolysis, and water regulation could be affected
[109,113,114].  However,  the  genes  involved  in  these
functions  are  unchanged  at  the  transcriptional  level.
Transcripts of glial markers such as carbonic anhydrase 2,
retinaldehyde-binding  protein  (Cralbp),  aquaporin  4,  and
glutamine synthase (Glul) stay highly expressed across most
MGCs (Appendix 6). However, dedifferentiation could occur
through  mislocalization  of  K+-channels  and  reduced
conductance [106] and result in the loss of function of neuron-
glia interaction (which requires a hyperpolarized membrane).
Such changes on a protein expression or localization level
would obviously not be identified on the RNA level as studied
here.
From a therapeutic point of view, MGCs remain available
for “modifications” after photoreceptor cell loss and could be
used for therapeutic strategies for retinal repair. MGCs could
be stimulated to reenter the cell cycle, express photoreceptor
specific genes, and potentially even undergo neurogenesis to
replace the lost photoreceptor cells. However, MGCs’ in vivo
potential to do so in mammals is ambiguous. At this point, it
is  also  unclear  how  well  newly  produced  photoreceptors
integrate and function. However, several recent studies of
engrafted photoreceptor cells suggest that the retina is indeed
able to respond to light following engraftment [115,116].
In consideration of the possibility that MGCs might be
able to regenerate photoreceptor cells, we compared the RP
and  WT  MGC  microarray  data  to  profiling  data  from
regenerating  zebrafish  tissues,  including  the  retina  [106],
heart [117], and fin [118]. Data from regenerating tissues
might help identify molecular triggers needed for MGCs’
acquisition of stem cell properties. Interestingly, many shared
upregulated  genes  across  three  studies  of  regeneration  in
zebrafish  fall  into  the  categories  of  cell  signaling,
immunoregulation,  regulation  of  transcription,  and  stress
response. These three categories are discussed above in the
context of RP, and a more detailed comparison revealed the
following similarities.
The proliferation marker Pcna (proliferating cell nuclear
antigen) was highly expressed in most MGCs at the late time
point in the Rhod-ko as well as in a subset of glia at the early
time points in both models, but surprisingly, also in a subset
(two of five) of WT MGCs. Kassen et al. [119] noticed that
Stat3 expression increased after light-induced PR death in
zebrafish  and  that  a  subset  of  Stat3  expressing  cells  also
express Pcna. The same observation was made for the MGC
data set (Figure 5). The immunoregulatory gene, Atf3, was
expressed in two out of five cells at week 25 in Rhod-ko.
Interestingly,  those  cells  also  expressed  Pcna.  Other
immunoregulatory genes such as Socs members and the tissue
inhibitor of metalloproteinase (Timp) were heterogeneously
expressed. Karyopherin alpha 2 (Kpna2), a gene associated
with protein import into the nucleus, which is expressed in
retinal progenitor cells during the S phase [49], showed high
expression values in the rd1 at P13. Nr1d2, a gene involved
in regulating transcription, was highly expressed at later time
points  in  both  models  and  heterogeneously  at  early  time
points, but not in P13 WT. Further work on the function of
these genes, potentially in the entry to cell cycle, will be
needed to interpret these intriguing changes.
Ascl1a  (proneural  bHLH)  and  Six3b  (early  eye
development) are transcription factors expressed in zebrafish
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[117]. Ascl1 was expressed in two WT cells and three of five
Rhod-ko cells during rod death. The levels were low (fewer
than 2,000), but since values within the other cells fluctuated
near 0, this may represent a significant upregulation. Six3 also
was  expressed  heterogeneously  across  MGCs  from
degenerating retina. As a side note, the transcription factor
Pax6, a retinal progenitor gene marker, was also expressed in
a subset of MGCs [27,120], and interestingly, a subset of those
Pax6 positive cells also were Pcna-positive. In keeping with
this correlation, a subset of PCNA-positive cells also were
Pax6 positive (three out of nine cells). Sox4a, a gene usually
expressed in committed neural progenitors, was upregulated
in one week 25 Rhod-ko MGC, and most of the rd1 P13 cells.
The negative regulator of bHLH genes, Id3, stayed high in all
of the MGCs. Also highly expressed in most of the cells from
degenerating retina as well as in a subset of WT cells at the
adult stage and all of the WT cells at P13 were the stress
response  genes,  Hspd1  (mitochondrial  chaperone  Hsp60),
Hspa5 (Hsp70), and calreticulin. These similarities between
the murine MGC data set and the zebrafish data imply that
MGCs indeed share some features with cells that are able to
regenerate their tissues. It would be interesting to know if only
a  sub-population  of  MGCs  was  maintained  to  potentially
produce neurons later or if all MGCs could be induced to do
so.
Inverse correlation with Gfap: Many genes appeared to be
inversely correlated with Gfap. The gene Emg1 (ribosome
synthesis factor/ methyltransferase) was one such gene. We
found 1,375 genes coregulated with Emg1, out of which 573
had p values of <0.01 (Figure 6 and Appendix 7). Function–
based  analysis  performed  with  the  DAVID  functional
annotation  tool  revealed  enrichment  for  the  following
categories (Figure 7): RNA binding and translation (Lsm4,
Eif4g2, Eif5a, Rps28, Syncrip), regulation of actin filament
based  processes  (Rac1,  Pfn1,  and  Rdx),  RNA  processing/
acetylation (Emg1, Lsm4, Tnpo1, Ube2l3, Pfn1, Rdx, Rsp28,
Scp2,  Syncrip),  catabolic  process/proteolysis  (Ube2l3,
Ube2z), and ion binding (Macf1, Plcb4, Slc31a2, Tns3). As
discussed  earlier,  glial  cells  are  crucial  in  modifying  the
activation thresholds and plasticity of neurons as well as their
communication, which might be particularly important during
photoreceptor cell death. A highly controlled network for
RNA  processing  might  allow  them  to  do  so.  Two  genes
involved  in  regulatory  mRNA  pathways,  Syncrip  (mRNA
transport and stabilization) and Lsm4 (mRNA decapping and
degradation), have been previously shown to be expressed in
glial cells [121]. Zebrafish regeneration studies [121] showed
a  predominant  number  of  downregulated  genes  (60%)  in
categories such as cell communication, signal transduction,
and  transcription  regulation  during  cell  death  and
regeneration. As one would predict, RNA processing has been
shown  to  be  involved  in  controlling  differentiation  from
neural stem cells [120], and RNA splicing has been previously
shown  to  be  an  important  process  for  adult  neurogenesis
[122].  Additionally,  downregulation  of  Rac1  in  the  CNS
allows  for  regeneration  in  the  sciatic  nerve  [123].  The
observed downregulation of these genes involved in mRNA
processing and transport in MGCs may therefore reflect a
reduced differentiation potential [124], which is consistent
with the absence of proliferation and dedifferentiation during
photoreceptor cell death in RP. This will be a critical issue to
address to be able to achieve progress in modifying MGCs as
a therapeutic approach for retina degenerations.
Conclusions: The data reported here provide a starting point
for analyses of MGC function during retinal degeneration.
Many hypotheses are possible given the number of functions
likely  performed  by  MGCs  in  normal  and  degenerating
retinas. Although the heterogeneity inherent in WT MGCs, as
well  as  the  potential  heterogeneity  in  response  to  injury,
makes a statistical analysis and validation difficult to perform,
functional tests for some pathways are suggested by the data
discussed above.
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1212Appendix 1. Full Affymetrix data set.
Signal levels of all 28 MGC arrays are represented in an
Excel table. To access the data, click or select the words
“Appendix 1.”  This  will  initiate  the  download  of  an Excel
(.xls)   archive   that contains the file. Signals from microarrays
were processed by using Affymetrix Suite Software (MAS
5.0). The resulting data was exported as tab delimited text file.
WT=wildtype,  Rhod-ko=Rhodopsin  knockout  model,
rd1=rd1 model, and cong FVB=congenic FVB. Time points
chosen are > 21 days for WT, and 8 weeks and 25 weeks for
the peaks of the two cell death waves in the Rhod-ko model.
The corresponding time points in the rd1 are postnatal day (P)
13 and 5 w. MGCs from congenic FVB at P13 were also
profiled as WT samples to closer age match the early cell death
wave in the rd1 model.
Appendix 2. Median expression distribution.
To access the data, click or select the words “Appendix
2.” This will initiate the download of a compressed (pdf)
archive  that  contains  the  file.  Multiple  probe  sets
corresponding to a single gene were combined by selecting
whatever probe set gave the highest value in a particular cell,
and  their  median  expression  was  calculated.  From  the
distribution of median expression levels over all cells on the
x-axis (logarithmic) an initial peak of low expressed genes
(probably off) on the left can be observed followed by a tail
on the right side (probably on). Red lines represent chosen
threshold levels.
Appendix 3. P value distribution for genes coregulated with the gliosis
marker Gfap.
To access the data, click or select the words “Appendix
3.” This will initiate the download of a compressed (pdf)
archive that contains the file. Gfap is represented with a green
line. Other genes are shown for comparison. x-axis=p value
threshold, y-axis=fraction of genes.
Appendix 4. Genes with similar expression patterns to Gfap.
To access the data, click or select the words “Appendix
4.” This will initiate the download of a compressed (pdf)
archive that contains the file. Multiple Affymetrix numbers
for the same probeset (the same gene according to Affymetrix
annotation) were collapsed using the maximum value for each
array. Significance cut-off for P value was chosen as <0.01,
corresponding  to  281  gene  hits.  The  first  three  columns
contain the information on the genes. The remaining column
contains the p-values for co-regulation between the gene in
that row and the gene in the column title.
Appendix 5. P values of genes associated with Ccnd3.
To access the data, click or select the words “Appendix
5.” This will initiate the download of a compressed (pdf)
archive that contains the file. The cut off was set at <0.01.
Gene information (Affymetrix ID and gene name) is shown
in the first three columns. The remaining column contains the
P values for co-regulation between the gene in that row and
Ccnd3.
Appendix 6. P values of genes associated with Chx10.
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6.” This will initiate the download of a compressed (pdf)
archive that contains the file. The cut off was set at <0.01.
Gene information (Affymetrix ID and gene name) is shown
in the first three columns. The remaining column contains the
P values for co-regulation between the gene in that row and
Chx10.
Appendix 7. Genes with inverse expression patterns to Gfap.
To access the data, click or select the words “Appendix
7.” This will initiate the download of a compressed (pdf)
archive  that  contains  the  file.  Emg1  was  chosen  as  co-
regulation marker. The significance cut off was set at 0.01.
Gene information (Affymetrix ID and gene name) is shown
in the first three columns. The remaining column contains the
P values for co-regulation between the gene in that row and
Emg1.
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